Skip to content
Grochi · Neutral pet information from South Korea · English edition한국어
Grochi.English edition
Health care

How do oral, spot-on, collar and injectable parasite medicines differ by form?

Translated from the Korean edition · Editorial draft, not professionally reviewed. This page is an English translation of the Korean edition as checked on 2026-11-22. If the two differ, the Korean edition is the reference. 한국어판 (Korean edition)

How do oral, spot-on, collar and injectable parasite medicines differ by form?
Short answer

Parasite medicines for pets come as oral medicines, spot-on liquids applied to the skin, collars, injections and other forms, and the route into the body and the points to check differ by form. This article only describes differences that the sources state and does not judge which form is better.

Key takeaways

  • The U.S. FDA explains that flea and tick products come in several forms, such as pills and chews given by mouth, collars, sprays, dips, shampoos, powders and liquids applied to the skin (spot-ons), and its guidance on what to do after an adverse reaction differs somewhat by form.
  • The Merck Veterinary Manual explains that isoxazolines are readily absorbed after oral or topical administration, that fipronil accumulates in the sebaceous glands of the skin, and that some ingredients are absorbed through the skin after being applied and distributed through the blood, so the route a medicine takes in the body is not the same across ingredients and forms.
  • In the United States, a standard has been used since the mid-1970s under which a chemical absorbed into the bloodstream is overseen by the FDA and one that remains on the skin is overseen by the EPA, and this split is a U.S. system different from the Korean division into veterinary medicinal products and veterinary quasi-drugs.
  • On July 13, 2023, the U.S. EPA announced that it was requiring measures such as added label warnings and a 5-year limited registration for one collar product, and the FDA advises removing a collar right away if it causes a bad reaction.
  • The FDA states that the dog injectable extended-release product whose approval it announced on July 10, 2025 can be prescribed only by a licensed veterinarian, and this article does not judge which form works better.

What changes with the form? The conclusion first

Parasite medicines can be made in several forms even with the same ingredient, such as oral medicines, spot-on liquids applied to the skin, collars, injections, and sprays and shampoos, and depending on the form, the route the medicine takes into the body, the points an owner should check, and the guidance after an adverse reaction differ. This article describes those differences only within what the U.S. FDA and EPA, the Merck Veterinary Manual, the American Heartworm Society (AHS) and Korean law state.

This article does not judge which form works better, is safer or is more convenient, because it could not find a source that directly compares the effects of the forms. It is not an article that tells you to choose a form, and it does not set a dose by weight or a dosing interval. The form that suits an animal should be decided with a veterinarian and the product instructions.

What forms exist, and how do the sources describe them?

The FDA's consumer update (content current as of 2021-06-22) explains that flea and tick products come as pills and chews given by mouth, collars, sprays, dips, shampoos, powders and liquids applied to the skin (spot-ons). It also states that some products are available only from a veterinarian, while others can be bought without a prescription.

The Merck Veterinary Manual chapter “Ectoparasiticides Used in Small Animals” describes the route in the body differently by ingredient. It says isoxazoline-class ingredients are readily absorbed after oral or topical administration and are active for 4–12 weeks. It says macrocyclic lactone-class ingredients are rapidly absorbed through the skin when applied and distributed via the blood, and that fipronil accumulates in the sebaceous glands of the skin. It says nitenpyram is rapidly absorbed as an oral medicine and more than 90% is excreted in the urine within 24–48 hours, and that lufenuron can be given by mouth to dogs or cats, or by injection to cats.

What can be read from these descriptions is that, even among ectoparasiticides, the sources describe some ingredients as spreading through the whole body via the blood and others as staying in the skin and sebaceous layer. This does not mean one form is better than another, and the same manual does not rank the forms by effect. The same manual advises reading the label carefully for ingredients, age and species restrictions, and directions for use.

This description comes from a U.S. source, so which forms are approved in Korea should be checked in the approval information.

Summary of what the sources state, by form (not a ranking of effect, not dosing instructions)
FormMechanism or characteristic the sources describePoints the sources say to checkWhat this article could not confirm
Oral medicine (pill or chew)Merck: isoxazolines are readily absorbed after oral administration; nitenpyram is rapidly absorbed and excreted in the urineCheck the label for ingredients and age and species restrictions (Merck); store the product out of reach of children and pets (FDA)Guidance for when a pet vomits or spits out the medicine (not in the sources opened)
Spot-on (liquid applied to the skin)Merck: fipronil accumulates in the sebaceous glands; some macrocyclic lactones are absorbed through the skin and distributed via the bloodSwimming and frequent bathing may shorten the duration of imidacloprid (Merck); keep the treated pet apart from other animals until dry (FDA)Details for each product approved in Korea
CollarMerck: lists impregnated collars as one of the delivery systems and gives a dog amitraz collar as an exampleRemove the collar right away if there is a bad reaction (FDA); label to carry an instruction to remove the collar (EPA)How the ingredient spreads from a collar
Extended-release injectionFDA: extended-release injectable suspension, protection of 8–12 months stated in the approval announcementPrescribed only by a licensed veterinarian (FDA)Injectable parasite products approved in Korea
Spray, shampoo or dipMerck: listed among the older delivery systemsContact a veterinarian right away if there is a bad reaction (FDA)How shampoos and dips work

What do the sources tell owners to check for oral and spot-on medicines?

An oral medicine is a form that is swallowed and absorbed from the digestive tract. The Merck Veterinary Manual explains that isoxazolines are readily absorbed after oral administration. What to check on the package of an oral medicine is the ingredient, the age and species restrictions, and the directions for use. The sources opened for this article had no guidance for when a pet vomits or spits out the medicine, so if that happens, check the product instructions and ask a veterinarian.

A spot-on is a liquid applied directly to the skin. The FDA explains that a spot-on is usually applied between the shoulder blades. According to the Merck Veterinary Manual, some ingredients are absorbed through the skin and distributed via the blood, fipronil accumulates in the sebaceous glands, and imidacloprid is readily soluble in water, so swimming and repeated bathing may shorten its duration of activity. An explanation of one ingredient cannot be applied as it is to every spot-on, so if you are concerned about bathing and swimming, read the product instructions and ask a veterinarian.

The FDA advises treating one pet at a time when there are several and keeping the treated animal apart until the product dries, so that animals do not groom one another and swallow the drug or pesticide. It also says to keep products out of reach of children and pets and to wash your hands with soap and water right after applying a product or to wear protective gloves. The Merck Veterinary Manual explains that contact dermatitis is rare but can occur at the site of application, and that cats in particular can show temporary excessive grooming, hyperesthesia, agitation or subdued behavior after a spot treatment. If such signs appear, check the product instructions and tell a veterinarian.

This article did not find direct guidance, in the sources it opened, on licking the area where a product was applied. If that happens, check the product instructions and ask a veterinarian.

What is different about collars, and what do the sources say to check?

A collar is a form in which a band coated with an ingredient is worn around the neck. The Merck Veterinary Manual lists impregnated collars as one of the delivery systems and describes an amitraz-impregnated dog collar for tick control as the only amitraz-containing product on the market. This article does not explain how the ingredient spreads from a collar.

The FDA advises removing a collar right away if it causes a bad reaction, and for spot-ons, shampoos and dips it advises contacting a veterinarian right away. In its 2023 announcement, the EPA had the label of one collar product carry the common adverse reactions and an instruction to remove the collar if they occur.

There is no direct guidance in the sources this article opened on a pet swallowing or chewing a collar, or on another animal chewing or licking one. If a collar comes loose, breaks or shows pieces, check the product instructions and ask a veterinarian.

How do the U.S. EPA and FDA divide flea and tick products, and what did they announce about a collar?

In the United States, flea and tick products for pets do not fall under a single agency. The EPA page “EPA's Regulation of Flea and Tick Products” explains that since the mid-1970s the EPA and the FDA have determined which agency oversees them, with the standard being that a chemical absorbed into the bloodstream is overseen by the FDA and one that remains on the skin is overseen by the EPA. The same page states that many of the topical products regulated by the EPA do not remain on the skin, and that in February 2023 the EPA and the FDA jointly released a whitepaper proposing a process for transferring oversight of flea and tick pet products from the EPA to the FDA. The page this article opened does not say whether that proposal has been finalized. This split is a U.S. system, and Korea uses a separate system that divides veterinary medicinal products (동물용의약품) from veterinary quasi-drugs (동물용의약외품).

This article confirmed two dated pieces of EPA public information about a collar.

  • July 13, 2021: The EPA issued a notice seeking comment on a petition from the Center for Biological Diversity. The petition asks the EPA to cancel the registration of one collar product containing flumethrin and imidacloprid and to suspend the registration pending cancellation; the comment period is stated as 60 days and the docket number as EPA-HQ-OPP-2021-0409.
  • July 13, 2023: The EPA announced that it was requiring additional mitigation measures for the same product. In outline: putting the common adverse reactions and an instruction to remove the collar if they occur on the label; an outreach program to inform veterinarians and the public; splitting the registration into one for dogs and one for cats and reporting incident and sales data to the EPA every year; evaluating possible changes to the emergency release mechanism and reporting within 1 year; and limiting this registration to 5 years so that incident reports can continue to be evaluated. The new requirements are to be reflected by the next label printing, that is, within 12 months.

In the same announcement, the EPA advises owners to discuss with a veterinarian when flea and tick control is needed and what type of product to use, to read the entire label and follow the directions, and to monitor the pet after treatment. This article does not interpret the incident or death counts in EPA materials to judge the safety of the collar.

Why is an injectable given only at an animal hospital?

On July 10, 2025, the FDA announced the approval of an extended-release injectable suspension for dogs aged 6 months and older against fleas and ticks (active ingredient fluralaner, an isoxazoline-class ingredient). The announcement explains that the product protects against fleas and ticks for 8–12 months, and states that whether the interval is 8 or 12 months is set by the veterinarian according to the tick species the dog is likely to encounter. It also says the product can be prescribed only by a licensed veterinarian, giving as the reason that professional expertise is required. The same announcement states that isoxazoline-class products have been associated with neurologic adverse reactions such as muscle tremors, ataxia and seizures.

On the heartworm prevention side, the AHS explains that preventives come as pills, spot-ons and injections, and that the injectable is given every 6 or 12 months. The same source states that FDA labeling calls for heartworm preventives to be used by or on the order of a licensed veterinarian, and that preventives must be obtained from a veterinarian or with a prescription through a pharmacy.

So the extent to which the sources answer “why only at an animal hospital” is that the approval announcement limited prescribing to licensed veterinarians and stated that professional expertise is required. How injectable parasite products are approved in Korea and who may administer them could not be confirmed in the Korean sources this article opened, so anyone considering an injectable should ask an animal hospital directly. Any abnormality you see at home after an injection should be reported to the hospital that gave it.

In Korea, what should I check regardless of form?

Korea does not have a structure divided between the EPA and the FDA as in the United States; instead, the Regulation on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) distinguishes veterinary medicinal products from veterinary quasi-drugs. Article 2(1)(1) of the same regulation defines a veterinary medicinal product (동물용의약품) as a medicinal product intended for use only on animals, and states that it includes companion-animal medicinal products. Article 2(1)(3)(a) treats as veterinary quasi-drugs (동물용의약외품) items such as pest-control agents that have a mild or no direct action on animals and are not instruments or machines, within the range notified by the head of the Animal and Plant Quarantine Agency (APQA) or the head of the National Fishery Products Quality Management Service. This article could not confirm that notification, so it does not state which form falls on which side.

Labeling requirements apply regardless of form. Article 42(1) requires the container or package and the package insert to mark a veterinary medicinal product as “veterinary medicinal product (동물용의약품)” and a veterinary quasi-drug as “veterinary quasi-drug (동물용의약외품)”, a companion-animal product as “companion-animal veterinary medicinal product (애완용 동물용의약품)”, and a prescription-only veterinary medicinal product (처방대상 동물용의약품) as such. Article 42(2) requires the container or package and the package insert to state the storage method, withdrawal period, contraindications, precautions and side effects set at product approval, along with the efficacy and effects. So whatever the form, reading the package and insert to see whether these items are stated is the starting point in Korea.

There is also a medication-guidance rule for pharmacy sales. Article 3-2(1) requires a pharmacist at an animal pharmacy and the managing pharmacist of a veterinary medicinal product wholesaler to give medication guidance to the animal owner when selling a prescription-only veterinary medicinal product or a veterinary medicinal product falling under one of the items of the same paragraph. Item 6 of those items is “veterinary insecticides and parasiticides (excluding companion-animal veterinary medicinal products)”. This means that an insecticide or parasiticide classified as a companion-animal veterinary medicinal product is left out of that item. It does not mean that all parasite medicines are subject to guidance, or that a companion-animal product is never subject to it; a product that is prescription-only or falls under another item is covered separately. Article 3-2(2) requires the guidance to include the medicine's name, intended animals, directions for use and dose, efficacy and effects, side effects and contraindications, withdrawal period, and storage method and expiry period, and to be given orally or in a written guidance document. This article could not confirm which products are classified as companion-animal veterinary medicinal products or prescription-only, so check the product label and approval information.

What should owners check regardless of form?

The items the FDA's consumer update lists regardless of form are as follows. Read the label again even for a product you have used many times, because the directions or warnings may have changed. Do not use a dog product on a cat. Use a product on puppies or kittens only when the label allows it for that life stage and the pet is above the minimum weight. Save the packaging in case a problem occurs and you need to report it. The FDA says to talk to a veterinarian before use on weak, old, medicated, sick, pregnant or nursing pets, and on pets that have shown sensitivity to such products before. Side effects might occur immediately or sometime later, and the FDA advises contacting a veterinarian if signs such as dizziness, wobbliness, poor appetite, vomiting, diarrhea or excessive salivation appear. It also states that some animals have had seizures or died.

The table below summarizes the checks for each form covered in this article and is not guidance for choosing a product.

What owners should check with the instructions and a veterinarian (within what the sources state, not treatment instructions)
What to checkApplicable formSource or where to check
Whether bathing or swimming affects how long it lastsSpot-on (varies by ingredient)Merck: swimming and frequent bathing may shorten the duration of imidacloprid; product instructions
Contact with children and other animalsSpot-onFDA: keep apart from other animals until dry, store out of reach of children, wash hands right after applying
Licking the area where it was appliedSpot-onNo direct guidance on licking in the sources opened; product instructions and a veterinarian
Adverse reaction to a collarCollarFDA: remove the collar right away if there is a bad reaction; consult a veterinarian
A collar swallowed or damagedCollarNo direct guidance in the sources opened; product instructions and a veterinarian
Vomiting or spitting out the medicineOral medicineNo direct guidance in the sources opened; product instructions and a veterinarian
Prescribing and administrationInjectionFDA: prescribed only by a licensed veterinarian; professional expertise required
Classification and labelingAll formsKorean regulation Article 42: labeling that distinguishes veterinary medicinal product, quasi-drug, companion-animal and prescription-only

What are common misconceptions about forms?

The first misconception is the judgment that “this form is best.” The sources opened for this article did not rank the forms by effect or safety. The characteristics of a form vary by ingredient and product.

The second is the idea that “a spot-on stays only on the skin, so there is no problem inside the body.” The Merck Veterinary Manual explains that some ingredients are absorbed through the skin and distributed via the blood, and the EPA also states that many of the topical products it regulates do not remain on the skin. Conversely, some ingredients, such as fipronil, accumulate in the sebaceous glands, so the route inside the body cannot be assumed from the name of the form alone.

The third is the idea that “once you have the injection, there is nothing more to watch.” The FDA states that neurologic adverse reactions have been associated with isoxazoline-class products, including an extended-release injectable, so any change you see at home after the injection should be reported to the hospital that gave it.

The fourth is the idea that “Korea has the same EPA and FDA split.” This split is a U.S. system, and Korea manages products through veterinary medicinal products and veterinary quasi-drugs, whether a product is prescription-only, and labeling that distinguishes companion-animal products.

The fifth is the idea that “U.S. collar product information can be applied as it is to products in Korea.” The EPA announcement concerns a specific product registered in the United States, and the approval and labeling of products sold in Korea should be checked in Korean information.

When should I contact a veterinarian?

In the following cases, contact an animal hospital rather than waiting while you read the instructions. If, after using a spot-on, a collar or a shampoo, the pet looks dizzy, wobbles, loses its appetite, or has vomiting, diarrhea or excessive salivation, contact a veterinarian right away. The FDA advises telling a veterinarian if these signs appear. If an animal wearing a collar has a bad reaction, take the collar off right away and contact a veterinarian. If tremors, wobbliness or seizures, which are signs of a neurologic problem, appear after an oral medicine or an injection, contact an animal hospital immediately.

If a dog product has been used on a cat or may have touched a cat, contact an animal hospital immediately. The FDA advises not to use a dog product on cats, and the Merck Veterinary Manual explains that some ingredients, such as permethrin, can be highly toxic to cats and cause muscle fasciculations and seizures.

This article does not set a course of treatment for when a pet vomits or spits out a medicine, licks the area where a product was applied, or may have swallowed a collar. Check the relevant guidance in the product instructions, and if you are unsure, ask a veterinarian. For a pet that is pregnant, nursing, young, on medication or sick, or that has been sensitive to similar products before, talk with a veterinarian first before deciding on a form.

Frequently asked questions

Q What forms do parasite medicines come in?

The FDA's consumer update explains that flea and tick products come as pills and chews given by mouth, collars, sprays, dips, shampoos, powders and liquids applied to the skin (spot-ons). An example of an extended-release injectable is the dog product whose approval the FDA announced on July 10, 2025. Which forms are available in Korea should be checked in the approval information.

Q Which works better, an oral medicine or a spot-on?

The sources opened for this article did not judge an effect ranking between forms, and Grochi does not either. The Merck Veterinary Manual only explains that the route into the body differs by ingredient. Which form suits a pet should be decided with a veterinarian who knows the pet's species, age and living environment.

Q Does bathing or swimming reduce the effect of a spot-on?

The Merck Veterinary Manual explains that imidacloprid is readily soluble in water, so swimming and repeated bathing may shorten its duration of activity. This is an explanation about that ingredient and cannot be applied as it is to other ingredients and products. Check the bathing and swimming guidance in the product instructions and ask a veterinarian.

Q How do the EPA and the FDA divide flea and tick products?

According to the EPA, since the mid-1970s a product absorbed into the bloodstream has been overseen by the FDA and one that remains on the skin by the EPA. The EPA states that many of the topical products it regulates do not remain on the skin, and in February 2023 the EPA and the FDA released a whitepaper proposing a process for transferring oversight from the EPA to the FDA. This is a U.S. system and differs from the Korean division into veterinary medicinal products and veterinary quasi-drugs.

Q When and what did the EPA announce about a collar?

On July 13, 2021, the EPA issued a notice seeking comment on a petition to cancel the registration of one collar product, and on July 13, 2023, it announced that it was requiring measures for the same product such as added label warnings, separate registrations for dogs and cats, evaluation of the emergency release mechanism, and a 5-year limited registration. This article does not judge safety from these measures.

Q Why is an injectable parasite medicine given only at an animal hospital?

The FDA's approval announcement states that the dog extended-release injectable product can be prescribed only by a licensed veterinarian and gives as the reason that professional expertise is required. How injectable parasite products are approved and administered in Korea could not be confirmed. Ask an animal hospital directly.

Limits and scope of this guide

This article is an editorial draft, and expert review by veterinarians or pharmacists has not been completed. It could not find a source that compares the effects or safety of the forms, and it does not judge which is better. For vomiting or spitting out a medicine, licking the area where a product was applied, and swallowing a collar, it could not find direct guidance in the sources it opened, so it only says to check the instructions and ask a veterinarian. It could not confirm how an ingredient spreads from a collar, how shampoos and dips work, which products and injectable products are approved in Korea by form, the range of the veterinary quasi-drug notification, or which parasite ingredients are designated companion-animal or prescription-only. The EPA materials concern the U.S. system and a specific product registered in the United States. Product recommendations, doses and dosing intervals are deliberately not covered. If a pet has symptoms or a medicine was used incorrectly, contact an animal hospital right away.

Translated from the Korean edition · Editorial draft, not professionally reviewed. The Korean edition is an explainer newly written from public sources; it is not a full translation of those sources. Veterinary expert review has not been completed. For decisions about your pet's health, talk to a veterinarian who knows your pet.

Sources and check dates

  1. Ectoparasiticides Used in Small Animals ↗

    Used as the basis for the route in the body after oral or topical administration by ingredient, the effect of bathing and swimming, contact dermatitis and hypersensitivity in cats, the advice to read labels, the list of delivery systems, and the explanation of permethrin toxicity in cats.

  2. Safe Use of Flea and Tick Products in Pets ↗

    Used as the basis for the list of product forms, reading labels, removing a collar after a bad reaction, contact with other animals and children and storage, and guidance on adverse signs (content current as of 2021-06-22).

  3. EPA's Regulation of Flea and Tick Products ↗

    Used as the basis for the split under which a chemical absorbed into the bloodstream is overseen by the FDA and one that remains on the skin by the EPA, and for the February 2023 whitepaper proposal.

  4. EPA Seeking Public Comment on Petition Related to Seresto Pet Collars (2021-07-13) ↗

    Used as the basis for the July 13, 2021 notice seeking comment on a petition to cancel a collar registration and for the ingredient listing.

  5. EPA Requires Additional Mitigation Measures for Seresto Pet Collars (2023-07-13) ↗

    Used as the basis for the July 13, 2023 label warnings, separate registrations, emergency release mechanism evaluation, 5-year limited registration and advice to owners.

  6. FDA Approves First Long-Acting Flea and Tick Treatment for Dogs (2025-07-10) ↗

    Used as the basis for the age of the dogs, the protection period, the licensed-veterinarian prescription statement and the neurologic adverse reaction statement for the extended-release injectable suspension.

  7. Heartworm Basics ↗

    Used as the basis for the pill, spot-on and injectable forms of preventives, the 6- and 12-month injection intervals, and the label statement on use under a veterinarian's direction.

  8. Regulation on the Handling of Veterinary Drugs, etc. (동물용 의약품등 취급규칙) ↗

    Used as the basis, within the current text in force from 2025-10-31, for Article 2(1)(1) and (3)(a), Article 3-2, and Article 42(1) and (2) (classification, medication guidance and labeling).

Korean edition checked · translated · each source may have a different check date. No paid partnerships.

This guide relies on 1 Korean law or notice. Current effective dates and upcoming amendments are listed on Korean law check status. This is not legal advice.